Medrio, a Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a CRO providing clinical trial services in the U.S. and Europe, have announced a new partnership under Medrio's Partner Program. Clinartis and Medrio have cultivated a business relationship through numerous phase I studies for which the CRO has utilized Medrio's flagship phase I-focused product, m1.
The Medrio Partner Program is a collaborative effort that aligns Medrio resources with trusted CROs and consultancies. The program is designed to offer extensive training, sales, product insights and marketing support to all partners.
"Medrio's robust, versatile and easy-to-deploy EDC system is a perfect fit for our dynamic and efficient operational mode," said Aramayis Kocharyan, vice president of Regulatory and Compliance at Clinartis. "This partnership with Medrio allows Clinartis to offer cutting-edge EDC solutions to support our sponsors' clinical development programs."
Clinartis is a full-service CRO based in Hollywood, Florida. Since 2011, Clinartis has provided customized solutions for clinical monitoring, site management, regulatory, data management, quality assurance and audit services to clients.
Medrio offers an integrated eClinical software platform with a fully hosted EDC system. The CloudEDC technology features an easy to use drag-and-drop interface, allowing study managers to build their studies in days instead of months without requiring any programming. Medrio's new mobile suite, mSource, supports both event-based and subject-based workflows, offline data entry, and Patient Reported Outcomes (PRO).